You are here

• Home
• Drug Products
• All Drug Products

• Multicentre Study to Explore the Correlation Between Smoking Pattern and Clinical Efficacy of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) in Male Patients

Disease

lung cancer

Drug Name

IRESSA

Generic Name

gefitinib

Sponsor

AstraZeneca

Drug Status

Approved Medicine

Phase

Non-Interventional Study

Start Date

Aug 24, 2009

Study Name

NIS-OTW-IRE-2009/1

Study Id

NIS-OTW-IRE-2009/1

ClinicalTrials.gov ID

NCT00922025

Recruiting Status

Open

Protocol Status

Not Available

Report

Nov 29, 2011

• NIS-OTW-IRE-2009/1.pdf (92 KB)

Page tools

• Print
• Bookmark this page